Wedescribe a patient with progressive systemic sclerosis whodeveloped ischemic colitis and scleroderma renal crisis following steroid pulse therapy. The possible pathogenic mechanisms of ischemic colitis and scleroderma renal crisis development are discussed. Weconclude that the administration ofsteroids in high doses, especially via steroid pulse therapy, should be undertaken with caution for progressive systemic sclerosis patients. (Internal Medicine 35: 583-586, 1996) 
Introduction
Steroid pulse therapy is used to treat various conditions including nephrotic syndrome, some collagen vascular diseases, and idiopathic interstitial pneumonia, for which its effectiveness has been widely accepted. Nevertheless facial flushing, gastrointestinal intolerance, hypertension, psychological disturbance, glucose intolerance, and sleep disturbance have been reported as side effects of steroid pulse therapy (1) . Moreover, moreserious side effects of steroid pulse therapy such as sudden death (1), life-threatening sepsis (2, 3) and myocardial infarction (2, 4) have also been reported.
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In this report, we describe a patient with progressive systemic sclerosis (PSS) who developed ischemic colitis and scleroderma renal crisis (SRC), following steroid pulse therapy.
Case Report
A 60-year-old womanwas admitted to hospital, in February 1 992, complaining ofdyspnea accompanied by non-productive cough, which had lasted for 6 months. She had experienced
Raynaud's phenomenon since December 1990, as well as flexion contracture of the fingers of both hands and depigmentation of the skin from February 1991. On examination, she presented normal blood pressure, contraction of the lingual frenulum, and mild anemia. Fine crackles were audible throughout the entire lung field as well as systolic murmurof the heart. Stool examination for occult blood was negative, but urinalysis showed a 2+ reaction for protein. (Fig. 2) , bleeding, and a decrease in ducts. Renal biopsy, which was carried out 5 months after the beginning of hemodialysis, revealed intimal hypertrophy ofinterlobular arteries and hyalinization in some glomeruli (Fig. 3) , although there was an absence of fibrinoid necrosis and amyloid deposit in the kidney. Neither the thickness of basal membranesnor an increase in mesangial cells were observed in glomeruli. Autopsy findings: Examination of the sigmoid colon revealed submucosal proliferation of vessels, although there were few abnormalities in the mucosa, which was considered repaired (Fig. 4) . Examination of the kidneys revealed hyalinization in some glomeruli, numerous hyaline cylinders in the renal tubules, and interstitial inflammatory cell infiltration. Intimal hypertrophy of interlobular arteries was noted (Fig. 5) . Examination of the mesenteric arteries revealed partial hypertrophy of the intima. 
Discussion
PSSis a systemic disease which involves not only skin, but also lungs, kidneys, skeletal muscle, the pericardium, and the gastrointestinal tract (6) . Gastrointestinal lesions are frequently found in the esophagus, small intestine, large intestine, and stomach, in that order, and the pathological findings are usually sclerosis of the connective tissue and smooth muscle atrophy (6) . The present case was diagnosed as ischemic colitis according to the criteria described by Williams and Wittenberg (7) matory fibrous intimal thickening and medial hypertrophy (6, 8) , whereas minor cases resembling overlapping PSS-polyarteritis nodosa reveal necrotizing vasculitis with fibrinoid degeneration (10) . In the case reported here, non-inflammatory fibrous intimal thickening was found in the interlobular arteries of the kidneys and in mesenteric arteries obtained at autopsy.
On the other hand, some drugs that induce thrombosis, such as oral contraceptives, are thought to trigger ischemic colitis (9) . Steroids also have thromboplastic activity and there are several reports of thrombosis and embolism induced by high-dose steroid administration. In this regard, in addition to the vascular and intestinal involvement associated with PSS, the thromboplastic activity of MPSLmay have triggered the development ofischemic colitis. To the best of our knowledge, this is the first reported case of ischemic colitis induced by steroid pulse therapy.
The present case was diagnosed as SRCdue to the rapid deterioration of renal function, hypertension, and retinopathy according topreviously established criteria (1 1 , 12 Further, development of ischemic colitis was rapidly followed by SRCwhich may have been caused by reduced renal blood flow due to the ischemic colitis, the effect of the corticosteroid, or both. Therefore, we consider that the administration of steroids should be undertaken with caution in cases ofPSS, and concomitant administration of anti-coagulants, such as warfarin, is recommendedto prevent such serious side effects when administering steroids in high doses, especially via steroid pulse therapy.
